{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:48:28Z","timestamp":1793188108295,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["75N91024C00011"],"award-info":[{"award-number":["75N91024C00011"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Colorectal Cancer (CRC) accounts for the second highest number of cancer-related mortalities rate worldwide, and its incidence and mortality is expected to continue to increase in the coming years. Over 80% of CRC cases are caused by mutation in the Adenomatous Polyposis Coli (APC) gene, a tumor suppressor gene involved in the Wnt signaling pathway that prevents uncontrolled cell growth. Familial Adenomatous Polyposis (FAP) is a rare, inherited, pediatric disorder characterized by the development of countless adenomatous (benign) polyps in the colon and\/or rectum, and over the patient\u2019s lifetime there is an almost 100% likelihood that the disorder will progress into CRC. In this study, we utilized bioinformatics to identify shared neoantigen epitopes present at the mutational cluster region (MCR) of the APC gene of multiple CRC patients, where FAP-associated mutation is typically observed. We then developed and optimized a chimeric virus-like particle (VLP) to encapsulate an saRNA replicon encoding a neoantigen construct featuring the identified mutated APC sequences inserted into a WT APC backbone. T-cell specific activation and restimulation against neoantigen peptide fragments were observed\n                    <jats:italic>in vitro<\/jats:italic>\n                    , indicating the capacity for a T-cell mediated response\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Serum samples from intramuscularly-dosed BALB\/c mice exhibited significant neoantigen-specific IgG titers compared against vehicle control and WT APC control mice, confirming VLP-expression of neoantigens and indicating neoantigen-specific\n                    <jats:italic>in vivo<\/jats:italic>\n                    immune activity. The significant response observed against the nanoparticle-expressed APC neoantigen serves as proof-of-concept for a saRNA-expressed cancer vaccine against APC-associated CRC.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1810178","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:35:13Z","timestamp":1780551313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification, design, and in vivo proof of concept of a shared APC neoantigen delivered via a self-amplifying RNA containing virus-like nanoparticle for cancer vaccination"],"prefix":"10.3389","volume":"17","author":[{"given":"Alfred J.","family":"Simmons","sequence":"first","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]},{"name":"Nanotherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Nikonova","sequence":"additional","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe D.","family":"Jonas","sequence":"additional","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Pniewski","sequence":"additional","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Upreti","sequence":"additional","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Perez","sequence":"additional","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Chimeron Bio Corporation","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70067","article-title":"Colorectal cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/ANNUREV-PATHOL-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/NATURE11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14071732","article-title":"Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies","volume":"14","author":"Hossain","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/35094067","article-title":"APC, signal transduction and genetic instability in colorectal cancer","volume":"1","author":"Fodde","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/S10689-020-00189-Y","article-title":"Chemoprevention in familial adenomatous polyposis: past, present and future","volume":"20","author":"Kemp Bohan","year":"2021","journal-title":"Fam Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/S13053-017-0065-X","article-title":"The genetic basis of colonic adenomatous polyposis syndromes","volume":"15","author":"Talseth-Palmer","year":"2017","journal-title":"Hered Cancer Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/HMG\/DDL464","article-title":"Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner","volume":"16","author":"Schneikert","year":"2007","journal-title":"Hum Mol Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/IJC.21826","article-title":"Truncated APC is required for cell proliferation and DNA replication","volume":"119","author":"Schneikert","year":"2006","journal-title":"Int J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/HMG\/DDR273","article-title":"APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC","volume":"20","author":"Schneikert","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/HMG\/11.13.1549","article-title":"The \u201cjust-right\u201d signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade","volume":"11","author":"Albuquerque","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/SJ.ONC.1206471","article-title":"Refining the relation between \u201cfirst hits\u201d and \u201csecond hits\u201d at the APC locus: the \u201cloose fit\u201d model and evidence for differences in somatic mutation spectra among patients","volume":"22","author":"Crabtree","year":"2003","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/12511","article-title":"The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson\u2019s \u201ctwo-hit\u201d hypothesis","volume":"5","author":"Lamlum","year":"1999","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.97.7.3352","article-title":"APC mutations in sporadic colorectal tumors: A mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits","volume":"97","author":"Rowan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2025.1574958","article-title":"Bispecific antibody targeting shared indel-derived neoantigen of APC","volume":"16","author":"Effenberger","year":"2025","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2025.1574955","article-title":"Identification of shared neoantigens derived from frameshift mutations in the APC gene","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.570241","article-title":"Immune microenvironment: New insight for familial adenomatous polyposis","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/VACCINES10111946","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/PATHOGENS12010138","article-title":"Self-amplifying RNA vaccine candidates: Alternative platforms for mRNA vaccine development","volume":"12","author":"Kumar Joshi","year":"2023","journal-title":"Pathogens"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/S41590-022-01359-Z","article-title":"The persistence of memory: Defining, engineering, and measuring vaccine durability","volume":"23","author":"Palin","year":"2022","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/S41541-024-01017-5","article-title":"A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines","volume":"9","author":"Ho","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/OXFIMM\/IQAC004","article-title":"Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets","volume":"3","author":"McKay","year":"2022","journal-title":"Oxf Open Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-025-04177-6","article-title":"Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade","volume":"32","author":"Gonzalez-Kozlova","year":"2026","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/S10616-013-9601-3","article-title":"Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring","volume":"66","author":"De Los Milagros Bassani Molinas","year":"2013","journal-title":"Cytotechnology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep36826","article-title":"Novel high-throughput approach for purification of infectious virions","volume":"6","author":"James","year":"2016","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100758","article-title":"A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses","volume":"2","author":"Cimen Bozkus","year":"2021","journal-title":"STAR Protoc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/S13045-022-01247-X","article-title":"Cancer vaccines as promising immuno-therapeutics: Platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/S41541-019-0103-Y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0203845","article-title":"A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity","volume":"13","author":"Majumder","year":"2018","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1255395","article-title":"Prophylactic vaccination targeting ERBB3 decreases polyp burden in a mouse model of human colorectal cancer","volume":"6","author":"Bautz","year":"2016","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:35:16Z","timestamp":1780551316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1810178"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1810178","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"article-number":"1810178"}}